"We have had very preliminary discussions after we signed the Caremark agreement because we couldn't (before) with the manufacturers and they're very promising, but they're early," Briner said
To date, Turner says he's lost 60 pounds, and his fatty liver disease has improved
Machine Learning Prediction of Financial Toxicity in Patients With Resected Lung Cancer 241(2):107-116, 2025
GLP-1 therapies are positioned as long-term treatments that modify biological drivers of weight, not short-term aids for dieting
The safest way to find out if semaglutide is right for you is to work with an experienced healthcare team
8 Semaglutide has been rigorously tested in human clinical trials, demonstrating an average placebo-corrected weight loss of approximately 12% over 68 weeks